ID

19125

Description

Clinical Trial of Gemcitabine and Oxaliplatin in Recurrent or Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00159458

Lien

https://clinicaltrials.gov/show/NCT00159458

Mots-clés

Versions (1)
  1. 06/12/2016 06/12/2016 -
Téléchargé le

6 décembre 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Recurrent Breast Cancer NCT00159458

Anglais

Eligibility Recurrent Breast Cancer NCT00159458

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically proven dx of recurrent or metastatic breast cancer
Description

Breast cancer recurrent | Breast Carcinoma TNM clinical staging

Type de données

boolean

Alias
UMLS CUI [1]
C0278493
UMLS CUI [2,1]
C0678222
UMLS CUI [2,2]
C3258246
must have received at least 1 but not more than 3 prior chemotherapy regimens for recurrent or metastatic breast cancer. patients who relapse within 12 months of completing adjuvant chemotherapy can only have had up to 2 prior regimens for metastatic disease. patients who relapse within 12 months of completing adjuvant chemotherapy containing an anthracycline and a taxane, do not require prior chemotherapy for metastatic disease.
Description

Chemotherapy Regimen Quantity Breast cancer recurrent | Chemotherapy Regimen Quantity Breast Carcinoma TNM clinical staging | Adjuvant Chemotherapy Completed | Recurrent disease | Anthracyclines | taxane

Type de données

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0278493
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C1265611
UMLS CUI [2,3]
C0678222
UMLS CUI [2,4]
C3258246
UMLS CUI [3,1]
C0085533
UMLS CUI [3,2]
C0205197
UMLS CUI [4]
C0277556
UMLS CUI [5]
C0282564
UMLS CUI [6]
C0215136
unidimensionally measurable dz (by recist)
Description

Measurable Disease Linear

Type de données

boolean

Alias
UMLS CUI [1,1]
C1513041
UMLS CUI [1,2]
C0205132
at least 18 yrs of age
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
swog ps 0-2
Description

SWOG performance status

Type de données

boolean

Alias
UMLS CUI [1,1]
C1519429
UMLS CUI [1,2]
C1518965
agc greater than or equal to 1.5; platelets greater than or equal to 100,000; hgb greater than or equal to 8.0
Description

Absolute neutrophil count | Platelet Count measurement | Hemoglobin measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0948762
UMLS CUI [2]
C0032181
UMLS CUI [3]
C0518015
total bilirubin less than or equal to 2 x uln; sgot and/or sgpt and alk phos up to 2.5 x uln
Description

Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Alkaline phosphatase measurement

Type de données

boolean

Alias
UMLS CUI [1]
C1278039
UMLS CUI [2]
C0201899
UMLS CUI [3]
C0201836
UMLS CUI [4]
C0201850
creatinine less than or equal to 2.0
Description

Creatinine measurement, serum

Type de données

boolean

Alias
UMLS CUI [1]
C0201976
fully recovered from acute toxicities secondary to prior tx
Description

Toxic effect Secondary to Therapeutic procedure | Patient Recovered

Type de données

boolean

Alias
UMLS CUI [1,1]
C0600688
UMLS CUI [1,2]
C0175668
UMLS CUI [1,3]
C0087111
UMLS CUI [2,1]
C0030705
UMLS CUI [2,2]
C0521108
signed informed consent (including hipaa authorization)
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
peripheral neuropathy grade 0-1
Description

Peripheral Neuropathy CTCAE Grades

Type de données

boolean

Alias
UMLS CUI [1,1]
C0031117
UMLS CUI [1,2]
C1516728
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior tx with gemcitabine or oxaliplatin. prior tx with cisplatin or carboplatin allowed if completed >12 mos prior to enrollment.
Description

gemcitabine | oxaliplatin | Cisplatin Completed | Carboplatin Completed

Type de données

boolean

Alias
UMLS CUI [1]
C0045093
UMLS CUI [2]
C0069717
UMLS CUI [3,1]
C0008838
UMLS CUI [3,2]
C0205197
UMLS CUI [4,1]
C0079083
UMLS CUI [4,2]
C0205197
underlying medical, psychiatric, or social conditions that would preclude patient from receiving tx
Description

Condition Excludes Therapeutic procedure

Type de données

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C0332196
UMLS CUI [1,3]
C0087111
peripheral neuropathy greater than or equal to gr 2
Description

Peripheral Neuropathy CTCAE Grades

Type de données

boolean

Alias
UMLS CUI [1,1]
C0031117
UMLS CUI [1,2]
C1516728
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
Retour au début de la page

Similar models

Eligibility Recurrent Breast Cancer NCT00159458

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Breast cancer recurrent | Breast Carcinoma TNM clinical staging
Item
histologically proven dx of recurrent or metastatic breast cancer
boolean
C0278493 (UMLS CUI [1])
C0678222 (UMLS CUI [2,1])
C3258246 (UMLS CUI [2,2])
Chemotherapy Regimen Quantity Breast cancer recurrent | Chemotherapy Regimen Quantity Breast Carcinoma TNM clinical staging | Adjuvant Chemotherapy Completed | Recurrent disease | Anthracyclines | taxane
Item
must have received at least 1 but not more than 3 prior chemotherapy regimens for recurrent or metastatic breast cancer. patients who relapse within 12 months of completing adjuvant chemotherapy can only have had up to 2 prior regimens for metastatic disease. patients who relapse within 12 months of completing adjuvant chemotherapy containing an anthracycline and a taxane, do not require prior chemotherapy for metastatic disease.
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0278493 (UMLS CUI [1,3])
C0392920 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0678222 (UMLS CUI [2,3])
C3258246 (UMLS CUI [2,4])
C0085533 (UMLS CUI [3,1])
C0205197 (UMLS CUI [3,2])
C0277556 (UMLS CUI [4])
C0282564 (UMLS CUI [5])
C0215136 (UMLS CUI [6])
Measurable Disease Linear
Item
unidimensionally measurable dz (by recist)
boolean
C1513041 (UMLS CUI [1,1])
C0205132 (UMLS CUI [1,2])
Age
Item
at least 18 yrs of age
boolean
C0001779 (UMLS CUI [1])
SWOG performance status
Item
swog ps 0-2
boolean
C1519429 (UMLS CUI [1,1])
C1518965 (UMLS CUI [1,2])
Absolute neutrophil count | Platelet Count measurement | Hemoglobin measurement
Item
agc greater than or equal to 1.5; platelets greater than or equal to 100,000; hgb greater than or equal to 8.0
boolean
C0948762 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
C0518015 (UMLS CUI [3])
Serum total bilirubin measurement | Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Alkaline phosphatase measurement
Item
total bilirubin less than or equal to 2 x uln; sgot and/or sgpt and alk phos up to 2.5 x uln
boolean
C1278039 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
C0201836 (UMLS CUI [3])
C0201850 (UMLS CUI [4])
Creatinine measurement, serum
Item
creatinine less than or equal to 2.0
boolean
C0201976 (UMLS CUI [1])
Toxic effect Secondary to Therapeutic procedure | Patient Recovered
Item
fully recovered from acute toxicities secondary to prior tx
boolean
C0600688 (UMLS CUI [1,1])
C0175668 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
C0030705 (UMLS CUI [2,1])
C0521108 (UMLS CUI [2,2])
Informed Consent
Item
signed informed consent (including hipaa authorization)
boolean
C0021430 (UMLS CUI [1])
Peripheral Neuropathy CTCAE Grades
Item
peripheral neuropathy grade 0-1
boolean
C0031117 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
gemcitabine | oxaliplatin | Cisplatin Completed | Carboplatin Completed
Item
prior tx with gemcitabine or oxaliplatin. prior tx with cisplatin or carboplatin allowed if completed >12 mos prior to enrollment.
boolean
C0045093 (UMLS CUI [1])
C0069717 (UMLS CUI [2])
C0008838 (UMLS CUI [3,1])
C0205197 (UMLS CUI [3,2])
C0079083 (UMLS CUI [4,1])
C0205197 (UMLS CUI [4,2])
Condition Excludes Therapeutic procedure
Item
underlying medical, psychiatric, or social conditions that would preclude patient from receiving tx
boolean
C0348080 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0087111 (UMLS CUI [1,3])
Peripheral Neuropathy CTCAE Grades
Item
peripheral neuropathy greater than or equal to gr 2
boolean
C0031117 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
Item Group
C0680251 (UMLS CUI)
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial